Pharma Intelligence Informatics Solutions, Datamonitor Healt...
Streamline your workflow with a new solution that delivers critical disease overviews back to you quickly, easily, and efficiently with the new Pharma360.
PD-1/PD-L1 Inhibitors: The First Wave of Immuno-Oncology is a comprehensive look at the immuno-oncology landscape, and includes:
· An overview of the current immuno-oncology market
· Ongoing developments in the PD-1/PD-L1 therapy space
· Challenges with PD-1/PD-L1 inhibitor development and treatment
· An examination of:
o Non-small cell lung cancer (NSCLC)
o Bladder cancer
· A look at the future of immuno-oncology
Watch webinar recording here
Datamonitor Healthcare: data analysis and insight
As the COVID-19 pandemic continues, governments worldwide have pinned their hopes on returning to normality on the development of a vaccine. With multiple vaccines currently in late-stage trials, there is promise that a successful vaccine will soon be ready.
Scrip: industry news and insights, Datamonitor Healthcare: d...
In 2019, the 10 most lucrative medicines generated combined global sales of $92.5B. Scrip provides insight into these top sellers and the companies behind them, as well US dynamics, global sales forecasts and lifecycle data, with complementary market analysis from Datamonitor Healthcare on diseases targeted, indications, and more.
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: